MALT1 and breast carcinoma: Amongst the tumor types in which NF-κB is activated through the CARD10-BCL10-MALT1 (C10BM) signalosome to promote tumorigenesis, there is a subset of angiotensin II receptor 1 (AGTR1)-positive luminal breast cancers with poor prognosis [82].